Historical record - last NADAC publication: 2/23/2022
Product Information
TOPIRAMATE 25 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.0352 per EA under NDC 69097081603. Its NADAC has been published 291 times since Aug 10, 2016.
Strength
25 mg/1
Manufacturer
Cipla USA Inc.NDC
69097081603
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
2/23/2022
Active Ingredients
TOPIRAMATEApproval Type
Generic (ANDA)
FDA Application
ANDA079162On Market Since
7/22/2016
Pharmacological Classes
Price Statistics
The NADAC for TOPIRAMATE 25 MG TABLET has been published 291 times since Aug 10, 2016, and over the history we have for it it has declined 2.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0352 per EA |
|---|---|
| All-time high | $0.0391 (Sep 14, 2016) |
| All-time low | $0.0254 (Nov 21, 2018) |
| Median price | $0.0333 |
| Average price | $0.0325 |
| Largest weekly change | -18.9% (Apr 17, 2019) |
| Weeks tracked | 291 |
| Tracking since | Aug 10, 2016 |
Generic Alternatives
The matcher finds 13 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 28% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TOPIRAMATE 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE 25 MG TABLET, manufactured by Cipla USA Inc., is $0.0352 per EA (NDC 69097081603), effective Mar 2, 2022.
How has the price of TOPIRAMATE 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for TOPIRAMATE 25 MG TABLET has declined 2.4%. It has been tracked across 291 weekly CMS publications since Aug 10, 2016.
What are the highest and lowest recorded NADAC prices for TOPIRAMATE 25 MG TABLET?
Since Aug 10, 2016, the NADAC for TOPIRAMATE 25 MG TABLET has ranged from a low of $0.0254 (Nov 21, 2018) to a high of $0.0391 (Sep 14, 2016), with a median of $0.0333 per EA.
Are there cheaper alternatives to TOPIRAMATE 25 MG TABLET?
Yes. 13 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TOPIRAMATE 25 MG TABLET, is $0.0254 per EA — about 28% below TOPIRAMATE 25 MG TABLET.
Who manufactures TOPIRAMATE 25 MG TABLET?
TOPIRAMATE 25 MG TABLET (NDC 69097081603) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification